Veradigm Inc (NASDAQ: MDRX) stock fell -1.96% on Monday to $12.50 against a previous-day closing price of $12.75. With 0.64 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.9 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $12.79 whereas the lowest price it dropped to was $12.47. The 52-week range on MDRX shows that it touched its highest point at $19.77 and its lowest point at $11.30 during that stretch. It currently has a 1-year price target of $16.25. Beta for the stock currently stands at 0.84.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MDRX was down-trending over the past week, with a drop of -3.03%, but this was down by -6.65% over a month. Three-month performance dropped to -3.03% while six-month performance rose 2.29%. The stock lost -31.73% in the past year, while it has lost -29.14% so far this year. A look at the trailing 12-month EPS for MDRX yields 0.38 with Next year EPS estimates of 0.90. For the next quarter, that number is 0.21. This implies an EPS growth rate of 7.55% for this year and 4.68% for next year.

Float and Shares Shorts:

On Oct 30, 2023, short shares totaled 10.38 million, which was 9.50% higher than short shares on Sep 28, 2023. In addition to Mr. Richard J. Poulton as the firm’s CEO & Director, Ms. Tejal Vakharia serves as its Senior VP of Marketing & Government Affairs, General Counsel and Chief Compliance Counsel.

Institutional Ownership:

Through their ownership of 105.51% of MDRX’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 89.96% of MDRX, in contrast to 58.48% held by mutual funds. Shares owned by individuals account for 45.35%. As the largest shareholder in MDRX with 14.68% of the stake, BlackRock Fund Advisors holds 16,034,836 shares worth 16,034,836. A second-largest stockholder of MDRX, The Vanguard Group, Inc., holds 13,992,618 shares, controlling over 12.81% of the firm’s shares. Dimensional Fund Advisors LP is the third largest shareholder in MDRX, holding 9,080,923 shares or 8.31% stake. With a 6.73% stake in MDRX, the iShares Core S&P Small Cap ETF is the largest stakeholder. A total of 7,350,613 shares are owned by the mutual fund manager. The Vanguard Total Stock Market ETF, which owns about 2.99% of MDRX stock, is the second-largest Mutual Fund holder. It holds 3,267,112 shares valued at 43.09 million. Vanguard Small Cap Index Fund holds 2.45% of the stake in MDRX, owning 2,679,131 shares worth 35.34 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for MDRX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With MDRX analysts setting a high price target of $26.00 and a low target of $13.00, the average target price over the next 12 months is $16.25. Based on these targets, MDRX could surge 108.0% to reach the target high and rise by 4.0% to reach the target low. Reaching the average price target will result in a growth of 30.0% from current levels.

Dividends & Yield:

In terms of dividends, MDRX has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and MDRX currently yields $––. In the past year, MDRX’s dividend yield has been $––, but when looking at the stock over the past five years, its yield has been $––. Accordingly, MDRX has a current buyback yield of $20.89. This was $20.89 for the TTM, and it was $14.24 for the past five years.

Summary of Insider Activity:

Insiders traded MDRX stock several times over the past three months with 0 Buys and 1 Sells. In these transactions, 0 shares were bought while 1,223 shares were sold. The number of buy transactions has increased to 3 while that of sell transactions has risen to 26 over the past year. The total number of shares bought during that period was 742,908 while 505,291 shares were sold.

Leave a Reply

Your email address will not be published. Required fields are marked *